Accessibility Menu
 
Repligen logo

Repligen

(NASDAQ) RGEN

Current Price$103.31
Market Cap$5.83B
Since IPO (1986)+909%
5 Year-40%
1 Year-19%
1 Month-21%

Repligen Financials at a Glance

Market Cap

$5.83B

Revenue (TTM)

$763.34M

Net Income (TTM)

$51.40M

EPS (TTM)

$0.91

P/E Ratio

113.80

Dividend

$0.00

Beta (Volatility)

1.45 (Average)

Price

$103.31

Volume

106,370

Open

$106.88

Previous Close

$103.31

Daily Range

$100.97 - $107.59

52-Week Range

$100.97 - $175.77

RGEN: Motley Fool Moneyball Superscore

60

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Repligen

Industry

Life Sciences Tools and Services

Employees

2,000

CEO

Olivier Dominique Loeillot, MBA

Headquarters

Waltham, MA 02453, US

RGEN Financials

Key Financial Metrics (TTM)

Gross Margin

50%

Operating Margin

9%

Net Income Margin

7%

Return on Equity

3%

Return on Capital

2%

Return on Assets

2%

Earnings Yield

0.88%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$5.83B

Shares Outstanding

56.41M

Volume

106.37K

Avg. Volume

1.02M

Financials (TTM)

Gross Profit

$347.62M

Operating Income

$59.58M

EBITDA

$164.30M

Operating Cash Flow

$117.42M

Capital Expenditure

$23.52M

Free Cash Flow

$93.90M

Cash & ST Invst.

$767.63M

Total Debt

$689.95M

Repligen Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$194.25M

+14.8%

Gross Profit

$98.48M

+8.5%

Gross Margin

50.70%

N/A

Market Cap

$5.83B

N/A

Market Cap/Employee

$3.28M

N/A

Employees

1,778

N/A

Net Income

$8.33M

+42.9%

EBITDA

$42.53M

+16.9%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Net Cash

$96.91M

+616.2%

Accounts Receivable

$151.55M

+2.8%

Inventory

$179.26M

+17.1%

Long Term Debt

$666.55M

-0.3%

Short Term Debt

$21.07M

+39.0%

Return on Assets

1.75%

N/A

Return on Invested Capital

2.40%

N/A

Free Cash Flow

$23.35M

+120.8%

Operating Cash Flow

$28.30M

+88.6%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
AVTRAvantor, Inc.
$7.94+0.89%
BIOBio-Rad Laboratories, Inc.
$246.27+1.13%
STVNStevanato Group S.p.A.
$17.99+0.73%
ATRAptarGroup, Inc.
$117.99+0.09%

Trending Stocks

Symbol / CompanyPricePrice Chg
ONDSOndas
$11.21+0.27%
FFord Motor Company
$14.48+0.07%
AIIORobo.ai
$5.64+1.16%
POETPoet Technologies
$20.57+0.43%

Questions About RGEN

What is the current price of Repligen?

Repligen is trading at $103.31 per share.

What is the 52-week range for Repligen?

Over the past 52 weeks, Repligen has traded between $100.97 and $175.77.

How much debt does Repligen have?

As of the most recent reporting period, Repligen reported total debt of $687.62M.

How much cash does Repligen have on hand?

Repligen reported $582.65M in cash and cash equivalents in its most recent financial results.

What is Repligen’s dividend yield?

Repligen does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.